Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 11/20 | 0.61 |
| ▸ | KDM5B | Q9UGL1 | 6/20 | 0.61 |
| ▸ | KDM5C | P41229 | 6/20 | 0.61 |
| ▸ | KDM5A | P29375 | 6/20 | 0.61 |
| ▸ | KDM4A | O75164 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.61 |
| ▸ | KDM2A | Q9Y2K7 | 4/20 | 0.61 |
| ▸ | KDM3A | Q9Y4C1 | 4/20 | 0.61 |
| ▸ | KDM6B | O15054 | 3/20 | 0.61 |
| ▸ | TET3 | O43151 | 1/20 | 0.61 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | ASPH | Q12797 | 1/20 | 0.61 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.61 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.61 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.61 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.61 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.61 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29527921 | 1.00 | KDM4C (0.61) | KDM4CKDM5BKDM5CKDM5AKDM4A | |
| Hydrochloric Acid SCHEMBL1256781 | 0.98 | KDM4C (0.59) | KDM4CKDM5BKDM5CKDM5AKDM4A | |
| Hydrochloric Acid SCHEMBL11077926 | 0.98 | KDM4C (0.59) | KDM4CKDM5BKDM5CKDM5AKDM4A | |
| Tert-Butylamine SCHEMBL28094088 | 0.91 | GABRP (0.55) | KDM4CKDM5BKDM5CKDM5AKDM4A | |
| SCHEMBL30083787 | 0.86 | KDM4C (0.55) | KDM4CKDM5BKDM5CKDM5AKDM4A | |
| SCHEMBL28990167 | 0.85 | CYP2C9 (0.54) | KDM4CKDM5BKDM5CKDM5AKDM4A | |
| SCHEMBL3356107 | 0.84 | UHRF1 (0.50) | KDM4CKDM5BKDM5CKDM5AKDM4A | |
| Methyl Isonicotinate SCHEMBL30268553 | 0.83 | KDM4E (0.63) | KDM4CKDM5BKDM5CKDM5AKDM4A | |
| SCHEMBL28472665 | 0.83 | KDM5A (0.47) | KDM4CKDM5BKDM5CKDM5AKDM4A | |
| SCHEMBL363432 | 0.83 | UHRF1 (0.48) | KDM4CKDM5BKDM5CKDM5AKDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1611 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687829-A1 | COMPOSITION FOR CARING FOR KERATIN MATERIALS | L'OREAL (FR) | 2026-02-11 | — | — | EP | claimed |
| US-20250381116-A1 | SOLUBILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME | OREAL (FR) | 2025-12-18 | — | — | US | claimed |
| WO-2025132825-A1 | 1H-IMIDAZO[4,5-C]QUINOLINE METAL-BASED COMPLEXES USEFUL AS MEDICAMENTS | FUNDACIÓN DONOSTIA INTERNATIONAL PHYSICS CENTER - DIPC (ES) | 2025-06-26 | — | — | WO | claimed |
| US-20250161201-A1 | COSMETIC COMPOSITION | THE BOOTS COMPANY PLC (GB) | 2025-05-22 | — | — | US | claimed |
| WO-2025091239-A1 | COMPOSITION IN THE FORM OF OIL-IN-WATER EMULSION | L'OREAL (FR) | 2025-05-08 | — | — | WO | claimed |
| WO-2025091220-A2 | COMPOSITION IN THE FORM OF OIL-IN-WATER EMULSION | L'OREAL (FR) | 2025-05-08 | — | — | WO | claimed |
| EP-4543408-A1 | SOLUBILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME | L'OREAL (FR) | 2025-04-30 | — | — | EP | claimed |
| CN-119753728-A | Preparation method of ordered defective indium cluster frame porous material for electrocatalytic conversion of carbon dioxide to urea | 东北师范大学 | 2025-04-04 | — | — | CN | claimed |
| CN-117757432-B | High-suspension grinding fluid suitable for large-size silicon wafer, preparation method and application | 江苏奥首材料科技有限公司 | 2025-01-03 | — | — | CN | claimed |
| EP-4479146-A1 | COSMETIC COMPOSITION | The Boots Company PLC (GB) | 2024-12-25 | — | — | EP | claimed |
| US-20110118261-A1 | BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS | GLAXO GROUP LIMITED | 2011-05-19 | — | — | US | claimed |
| EP-2231646-A1 | BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS | GlaxoSmithKline LLC (US) | 2010-09-29 | — | — | EP | claimed |
| WO-2009076387-A1 | BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2009-06-18 | — | — | WO | claimed |
| CN-101343366-A | Nano-laminal compound with regular array of pyridine and its derivant, and preparation thereof | UNIV SHANGHAI (CN) | 2009-01-14 | — | — | CN | claimed |
| WO-2008013334-A1 | DEFORMYLASE INHIBITOR, PROCESS FOR THE PREPARATION THEREOF, AND COMPOSITION COMPRISING THE SAME | PROMEDITECH INC. (KR) | 2008-01-31 | — | — | WO | claimed |
| EP-1367985-A2 | ANHYDROUS ANTIPERSPIRANT AND DEODORANT COMPOSITIONS CONTAINING A SOLID, WATER-SOLUBLE, SKIN ACTIVE AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2003-12-10 | — | — | EP | claimed |
| EP-0896522-B1 | METHODS OF REGULATING SKIN APPEARANCE WITH VITAMIN B 3 COMPOUND | PROCTER & GAMBLE (US) | 2003-10-22 | — | — | EP | claimed |
| WO-2002069916-A2 | ANHYDROUS ANTIPERSPIRANT AND DEODORANT COMPOSITIONS CONTAINING A SOLID, WATER-SOLUBLE, SKIN ACTIVE AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2002-09-12 | — | — | WO | claimed |
| US-6383476-B1 | Anhydrous antiperspirant and deodorant compositions containing a solid, water-soluble, skin active agent | THE PROCTER & GAMBLE COMPANY | 2002-05-07 | — | — | US | claimed |
| EP-0095341-B1 | PENICILLANIC ACID DIOXIDE PRODRUG | PFIZER INC. (US) | 1986-02-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250161201-A1 | COSMETIC COMPOSITION | CYP19A1, SHBG, HSD17B11 | KDM4C 2767/4885KDM5B 2910/4885KDM5C 2390/4885 |
| US-20110118261-A1 | BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS | MCHR1, MCHR2, MC1R | KDM4C 2471/4885KDM5B 1744/4885KDM5C 2187/4885 |
| US-20250381116-A1 | SOLUBILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME | TBCB, CCNB3, CYP24A1 | KDM4C 563/4885KDM5B 953/4885KDM5C 1412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.